Depression affects millions worldwide, and while the focus is often on mental health, it can also impact physical well-being, including hair health. Many people notice hair thinning or shedding during depressive episodes, which can be due to stress, hormonal changes, or underlying medical conditions.

When treating depression, various types of antidepressants are prescribed to help restore chemical balance in the brain. However, some antidepressants are known to cause hair loss due to depression as a side effect. Understanding which medications affects hair growth is important for patients, caregivers, and healthcare providers alike.

1. Fluoxetine (Prozac)

Fluoxetine belongs to the class of Selective Serotonin Reuptake Inhibitors (SSRIs). Fluoxetine is FDA-approved (since 1987) for treating major depressive disorder, obsessive-compulsive disorder (OCD), panic disorder, bulimia nervosa, and premenstrual dysphoric disorder (PMDD).

Does Fluoxetine Cause Hair Loss?

Yes, prozac hair loss has been reported as a possible side effect, though it is relatively rare. Prozac hair loss is listed as an uncommon to rare side effect (occurs in less than 1% of users).

2. Sertraline (Zoloft)

Sertraline belongs to the class of Selective Serotonin Reuptake Inhibitors (SSRIs). Sertraline is FDA-approved (since 1991) for major depressive disorder, panic disorder, post-traumatic stress disorder (PTSD), social anxiety disorder, premenstrual dysphoric disorder (PMDD), and obsessive-compulsive disorder (OCD).

Does Sertraline Cause Hair Loss?
Yes, zoloft hair loss (sertraline hair loss) has been reported, though it is considered an uncommon to rare side effect with less than 1% of users.

3. Paroxetine (Paxil)

Paroxetine belongs to the class of Selective Serotonin Reuptake Inhibitors (SSRIs). Paroxetine is FDA-approved (since 1992) for major depressive disorder, generalized anxiety disorder, social anxiety disorder, panic disorder, obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD).

Does Paroxetine Cause Hair Loss?
Yes, paxil hair loss has been reported, though it is an uncommon to rare side effect with less than 1% of users experiencing it.

4. Escitalopram (Lexapro)

Escitalopram belongs to the class of Selective Serotonin Reuptake Inhibitors (SSRIs). Escitalopram is FDA-approved (since 2002) for major depressive disorder and generalized anxiety disorder.

Does Escitalopram Cause Hair Loss?
Yes, lexapro hair loss (escitalopram hair loss) has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

5. Citalopram (Celexa)

Citalopram belongs to the class of Selective Serotonin Reuptake Inhibitors (SSRIs). Citalopram is FDA-approved (since 1998) for the treatment of major depressive disorder.

Does Citalopram Cause Hair Loss?
Yes, celexa hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

6. Venlafaxine (Effexor)

Venlafaxine belongs to the class of Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs). Venlafaxine is FDA-approved (since 1993) for major depressive disorder, generalized anxiety disorder, panic disorder, and social anxiety disorder.

Does Venlafaxine Cause Hair Loss?
Yes, effexor hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

7. Duloxetine (Cymbalta)

Duloxetine belongs to the class of Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs). Duloxetine is FDA-approved (since 2004) for major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain.

Does Duloxetine Cause Hair Loss?
Yes, cymbalta hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

8. Amitriptyline

Amitriptyline belongs to the class of Tricyclic Antidepressants (TCAs). Amitriptyline is FDA-approved (since 1961) for depression, and it is also widely used off-label for migraines, neuropathic pain, and insomnia.

Does Amitriptyline Cause Hair Loss?
Yes, amitriptyline hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

9. Nortriptyline

Nortriptyline belongs to the class of Tricyclic Antidepressants (TCAs). Nortriptyline is FDA-approved (since 1964) for depression, and it is also commonly prescribed off-label for chronic pain, migraines, and smoking cessation support.

Does Nortriptyline Cause Hair Loss?
Yes, nortriptyline hair loss has been reported, though it is an uncommon to rare side effect with less than 1% of users experiencing it.

10. Imipramine

Imipramine belongs to the class of Tricyclic Antidepressants (TCAs). Imipramine is FDA-approved (since 1959) for depression and enuresis (bedwetting in children).

Does Imipramine Cause Hair Loss?
Yes, imipramine hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

11. Bupropion (Wellbutrin)

Bupropion belongs to the class of Atypical Antidepressants, specifically a Norepinephrine-Dopamine Reuptake Inhibitor (NDRI). Bupropion is FDA-approved (since 1985) for depression, seasonal affective disorder (SAD), and smoking cessation. It is also marketed in combination as Auvelity (bupropion + dextromethorphan) for major depressive disorder.

Does Bupropion Cause Hair Loss?
Yes, wellbutrin hair loss (auvelity hair loss) has been reported. It is considered an uncommon to rare side effect, with less than 1% of users experiencing it.

12. Mirtazapine (Remeron)

Mirtazapine belongs to the class of Atypical Antidepressants, specifically a Noradrenergic and Specific Serotonergic Antidepressant (NaSSA). Mirtazapine is FDA-approved (since 1996) for the treatment of major depressive disorder.

Does Mirtazapine Cause Hair Loss?
Yes, remeron hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

13. Phenelzine (Nardil)

Phenelzine belongs to the class of Monoamine Oxidase Inhibitors (MAOIs). Phenelzine is FDA-approved (since 1961) for major depressive disorder, especially in patients who have not responded to other antidepressants.

Does Phenelzine Cause Hair Loss?
Yes, phenelzine hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

14. Tranylcypromine (Parnate)

Tranylcypromine belongs to the class of Monoamine Oxidase Inhibitors (MAOIs). Tranylcypromine is FDA-approved (since 1961) for the treatment of major depressive disorder.

Does Tranylcypromine Cause Hair Loss?
Yes, tranylcypromine hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

15. Trazodone

Trazodone belongs to the class of Atypical Antidepressants, specifically a Serotonin Antagonist and Reuptake Inhibitor (SARI). Trazodone is FDA-approved (since 1981) for the treatment of depression. It is also widely prescribed off-label for insomnia and anxiety.

Does Trazodone Cause Hair Loss?
Yes, trazodone hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

16. Vilazodone (Viibryd)

Vilazodone belongs to the class of Atypical Antidepressants, working as a Selective Serotonin Reuptake Inhibitor (SSRI) and a 5-HT1A receptor partial agonist. Vilazodone is FDA-approved (since 2011) for the treatment of major depressive disorder.

Does Vilazodone Cause Hair Loss?
Yes, viibryd and hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

17. Buspirone

Buspirone belongs to the class of Anxiolytics, specifically a Serotonin 5-HT1A receptor partial agonist. Although not technically an antidepressant, it is often prescribed alongside them for anxiety disorders. Buspirone is FDA-approved (since 1986) for the treatment of generalized anxiety disorder (GAD).

Does Buspirone Cause Hair Loss?
Yes, buspirone hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

18. Desvenlafaxine (Pristiq)

Desvenlafaxine belongs to the class of Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs). Desvenlafaxine is FDA-approved (since 2008) for the treatment of major depressive disorder.

Does Desvenlafaxine Cause Hair Loss?
Yes, pristiq hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

19. Vortioxetine (Trintellix)

Vortioxetine belongs to the class of Atypical Antidepressants, functioning as a Serotonin Modulator and Stimulator (SMS). Vortioxetine is FDA-approved (since 2013) for the treatment of major depressive disorder.

Does Vortioxetine Cause Hair Loss?
Yes, trintellix hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

20. Maprotiline

Maprotiline belongs to the class of Tetracyclic Antidepressants (TeCAs). Maprotiline is FDA-approved (since 1980) for the treatment of depression.

Does Maprotiline Cause Hair Loss?
Yes, maprotiline hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

21. Reboxetine

Reboxetine belongs to the class of Norepinephrine Reuptake Inhibitors (NRIs). Reboxetine is approved in Europe and other countries, but it is not FDA-approved in the United States.

Does Reboxetine Cause Hair Loss?
Yes, reboxetine hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

22. Selegiline (Eldepryl, EMSAM)

Selegiline belongs to the class of Monoamine Oxidase Inhibitors (MAOIs). Selegiline is FDA-approved for Parkinson’s disease (Eldepryl) and depression (EMSAM patch).

Does Selegiline Cause Hair Loss?
Yes, eldepryl hair loss (emsam hair loss) has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

23. Isocarboxazid (Marplan)

Isocarboxazid belongs to the class of Monoamine Oxidase Inhibitors (MAOIs). Isocarboxazid is FDA-approved (since 1960s) for the treatment of major depressive disorder.

Does Isocarboxazid Cause Hair Loss?
Yes, marplan hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

24. Doxepin

Doxepin belongs to the class of Tricyclic Antidepressants (TCAs). Doxepin is FDA-approved (since 1969) for depression and anxiety, and is also widely used off-label for insomnia.

Does Doxepin Cause Hair Loss?
Yes, doxepin hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

25. Clomipramine (Anafranil)

Clomipramine belongs to the class of Tricyclic Antidepressants (TCAs). Clomipramine is FDA-approved (since 1989) for obsessive-compulsive disorder (OCD) and depression.

Does Clomipramine Cause Hair Loss?
Yes, clomipramine hair loss (anafranil hair loss) has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

26. Rasagiline (Azilect)

Rasagiline belongs to the class of Monoamine Oxidase-B Inhibitors (MAO-B inhibitors). Rasagiline is FDA-approved (since 2006) primarily for Parkinson’s disease. Its use as an antidepressant is off-label in some countries.

Does Rasagiline Cause Hair Loss?
Yes, azilect hair loss (rasagiline hair loss) has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

27. Agomelatine (Valdoxan)

Agomelatine belongs to the class of Atypical Antidepressants, functioning as a Melatonergic agonist and 5-HT2C antagonist. Agomelatine is approved in Europe and other countries for major depressive disorder but is not FDA-approved in the United States.

Does Agomelatine Cause Hair Loss?
Yes, valdoxan hair loss (agomelatine hair loss) has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

28. Esketamine (Spravato)

Esketamine belongs to the class of NMDA receptor antagonists, used as a rapid-acting antidepressant. Esketamine is FDA-approved (since 2019) for treatment-resistant depression in conjunction with an oral antidepressant.

Does Esketamine Cause Hair Loss?
Yes, spravato hair loss has been reported, though it is considered an uncommon to rare side effect with less than 1% of users experiencing it.

What Are the Types of Antidepressants that Cause Hair Loss?

Antidepressants are grouped into 5 different classes, each targeting brain chemistry in slightly different ways. While all are designed to ease symptoms of depression and anxiety, certain types have been more commonly reported to cause hair loss as a side effect. Shedding is usually temporary and rare, but understanding which categories are most linked to this issue can help patients make informed choices.

The main classes of antidepressants associated with hair thinning or shedding include:

SSRIs (Selective Serotonin Reuptake Inhibitors): These medications increase serotonin levels in the brain by preventing its reabsorption (reuptake).
SNRIs (Serotonin–Norepinephrine Reuptake Inhibitors): These drugs affect both serotonin and norepinephrine, two key neurotransmitters that influence mood.
TCAs (Tricyclic Antidepressants): An older class of antidepressants that affects several neurotransmitters, including serotonin and norepinephrine.
MAOIs (Monoamine Oxidase Inhibitors): These work by blocking the enzyme monoamine oxidase, which breaks down serotonin, dopamine, and norepinephrine.
Atypical Antidepressants: A diverse group that does not fit neatly into the above categories. They work through different mechanisms, such as influencing dopamine or melatonin pathways.

By categorizing antidepressants this way, patients and doctors can better understand which drug types are more likely to trigger hair loss and weigh treatment benefits against possible cosmetic concerns.

Which SSRIs Antidepressants Are Most Commonly Linked to Hair Loss in Patients?

When discussing SSRI hair loss, it is important to note that this side effect is considered uncommon, but it is medically recognized. SSRIs and hair loss are most often linked through case reports describing a temporary condition known as telogen effluvium, where hair prematurely enters the shedding phase.

Fluoxetine (Prozac): Hair loss is very rare, affecting fewer than 1% of patients, and is documented mostly through case reports. Norfluoxetine, its active metabolite, strongly influences serotonin pathways, which may disrupt the hair growth cycle. A case report in the Journal of Clinical Psychopharmacology described fluoxetine-induced hair loss that resolved after discontinuation.
Sertraline (Zoloft): Hair loss is rare, with several published case reports documenting the effect. Sertraline alters serotonin regulation, which may interfere with normal follicle cycling. A report in International Journal of Dermatology linked sertraline to telogen effluvium that improved after the medication was stopped.
Paroxetine (Paxil): Rare cases of paroxetine-induced hair loss have been reported. The mechanism is thought to involve serotonin-related changes in the follicle cycle. A published case in Clinical Neuropharmacology showed hair shedding that resolved after paroxetine withdrawal, with recurrence upon rechallenge.
Escitalopram (Lexapro): Hair loss is considered rare but has been noted in case reports. Escitalopram’s strong serotonergic action may alter melatonin–serotonin balance in follicles. A case study in Annals of Pharmacotherapy described dose-related hair loss associated with escitalopram that reversed after discontinuation.
Citalopram (Celexa): Very few cases have been reported, but citalopram may trigger telogen effluvium in sensitive patients. A case report in the Journal of Clinical Psychiatry detailed hair regrowth following the discontinuation of citalopram.
Fluvoxamine: Hair loss linked to fluvoxamine is extremely rare but has been documented. Like other SSRIs, it is thought to trigger hair shedding through serotonin-related follicle cycle disruption. A report in Psychopharmacology Bulletin described fluvoxamine-associated alopecia that resolved after stopping the drug.

Which SNRIs Antidepressants Are Most Commonly Linked to Hair Loss in Patients?

SNRIs (Serotonin–Norepinephrine Reuptake Inhibitors) act on both serotonin and norepinephrine, and these neurotransmitter shifts may interfere with the normal hair growth cycle.

Venlafaxine (Effexor): Hair loss is rare but has been reported in several case studies. Venlafaxine increases both serotonin and norepinephrine levels, which may alter follicle cycling. A case report in the Journal of Clinical Psychopharmacology described venlafaxine-induced alopecia that resolved following drug withdrawal.
Duloxetine (Cymbalta): Hair loss is uncommon and documented mainly through case reports. Duloxetine’s dual effect on serotonin and norepinephrine could influence hair follicle regulation. A published case in the Primary Care Companion for CNS Disorders reported duloxetine-related hair loss that reversed after discontinuation.
Desvenlafaxine (Pristiq): Very rare cases have been observed. As the active metabolite of venlafaxine, desvenlafaxine shares a similar pharmacological profile that may trigger telogen effluvium in sensitive patients. A case report in the Indian Journal of Pharmacology described hair shedding associated with desvenlafaxine use.

Which Tricyclic Antidepressants Are Most Commonly Linked to Hair Loss in Patients?

The connection between TCAs and hair loss is usually through telogen effluvium, where hair follicles prematurely enter the shedding phase. Compared to SSRIs and SNRIs, TCAs may pose a slightly higher risk due to their broader pharmacological effects, including anticholinergic activity and interactions with neurotransmitters beyond serotonin.

Amitriptyline: Hair loss is considered rare but has been reported in case studies. Amitriptyline’s strong anticholinergic and serotonergic actions may disrupt the follicle cycle. A case published in the Journal of Clinical Psychiatry described telogen effluvium that resolved after stopping amitriptyline.
Nortriptyline: Very few reports exist, but nortriptyline has been implicated in rare cases of drug-induced alopecia. The proposed mechanism involves changes in noradrenaline and serotonin regulation affecting hair growth. A report in Clinical Neuropharmacology described reversible alopecia following nortriptyline treatment.
Imipramine: Documented cases link imipramine to telogen effluvium, though the incidence is very low. Imipramine’s inhibition of serotonin and norepinephrine reuptake may trigger hair shedding. A case study in the International Journal of Dermatology noted improvement after discontinuation.
Clomipramine: Rare cases of clomipramine-induced alopecia have been reported. Its strong serotonergic action is thought to alter the follicle growth cycle. A published case in European Psychiatry described hair loss that reversed after withdrawal.
Doxepin: Hair loss is extremely rare but has been observed. Doxepin’s antihistaminic and antidepressant effects may play a role in follicle disruption. A case report in Dermatologic Therapy linked doxepin use to temporary alopecia.
Desipramine: Reports of desipramine-induced hair loss are rare but exist. Its noradrenergic action may influence follicle cycling in sensitive individuals. A case study in Journal of Affective Disorders highlighted resolution of alopecia after discontinuation.

Which MAOIs Antidepressants Are Most Commonly Linked to Hair Loss in Patients?

MAOIs influence serotonin, norepinephrine, and dopamine levels by inhibiting the enzyme monoamine oxidase. This broad neurotransmitter effect may indirectly disrupt the hair growth cycle and lead to telogen effluvium in susceptible individuals.

Phenelzine (Nardil): Rare reports link phenelzine to hair loss. Its strong inhibition of both MAO-A and MAO-B alters multiple neurotransmitter systems, which may affect follicle cycling. A case published in the Journal of Clinical Psychiatry described reversible hair loss after phenelzine use.
Tranylcypromine (Parnate): Very uncommon, but tranylcypromine has been associated with hair shedding in isolated reports. Its amphetamine-like properties and broad neurotransmitter effects may play a role. A case study in Clinical Neuropharmacology noted improvement in alopecia after discontinuation.
Isocarboxazid (Marplan): Extremely rare, but some case documentation exists. Its effect on serotonin and norepinephrine levels may trigger premature follicle transition into the shedding phase. A report in the International Journal of Dermatology described hair regrowth after stopping isocarboxazid.
Selegiline (Eldepryl, EMSAM patch): Primarily used in Parkinson’s disease and sometimes depression, selegiline has very limited evidence linking it to hair loss. A case published in Psychopharmacology Bulletin mentioned reversible alopecia after transdermal selegiline therapy.

Which Atypical Antidepressants Are Most Commonly Linked to Hair Loss in Patients?

Atypical antidepressants include a diverse group of medications that do not fit neatly into SSRIs, SNRIs, or TCAs. They act on various neurotransmitters, including serotonin, norepinephrine, and dopamine. Hair loss linked to atypical antidepressants is generally rare and usually reversible, often presenting as telogen effluvium.

Bupropion (Wellbutrin, Auvelity): Hair loss is rare but has been documented in several case reports. Bupropion’s norepinephrine–dopamine reuptake inhibition may alter follicle cycling. A report in Annals of Pharmacotherapy described bupropion-induced hair shedding that resolved after discontinuation.
Mirtazapine (Remeron): Hair loss is uncommon, reported in isolated cases. Its noradrenergic and specific serotonergic (NaSSA) activity may influence hair follicles. A case report in the Journal of Clinical Psychopharmacology described reversible hair loss after stopping mirtazapine.
Trazodone: Hair loss is very rare. As a serotonin antagonist and reuptake inhibitor (SARI), it may affect the follicle growth cycle. A case in Clinical Neuropharmacology documented telogen effluvium linked to trazodone that improved after discontinuation.
Vilazodone (Viibryd): Reports of hair loss are extremely limited. Its combined SSRI and partial serotonin receptor agonist activity may influence hair follicle cycles. A case in the International Journal of Psychiatry in Clinical Practice described reversible alopecia after stopping vilazodone.
Vortioxetine (Trintellix): Very rare cases reported. Its multimodal serotonergic activity could theoretically trigger hair shedding. A case in Psychiatry and Clinical Neurosciences documented hair regrowth following discontinuation.
Buspirone: Though primarily an anxiolytic, it is sometimes grouped with atypical antidepressants. Hair loss is extremely rare, with few documented cases. A report in Clinical Neuropharmacology described hair regrowth after stopping buspirone.

Which Newer Antidepressants Are Most Commonly Linked to Hair Loss in Patients?

Newer antidepressants include recently developed medications with mechanisms that differ from traditional SSRIs, SNRIs, TCAs, and MAOIs. Hair loss is rare with these drugs, but a few case reports suggest a potential link through telogen effluvium, where hair prematurely enters the shedding phase.

Esketamine (Spravato): Hair loss is extremely rare. Esketamine’s NMDA receptor antagonism may indirectly influence hair follicle cycling. A case report in Journal of Affective Disorders documented reversible hair shedding following treatment with esketamine.
Agomelatine (Valdoxan): Hair loss is very rare, with minimal documentation. As a melatonergic agonist and serotonin receptor antagonist, agomelatine may affect hair growth indirectly. A report in Human Psychopharmacology noted hair regrowth after discontinuation.
Rasagiline (Azilect): Used primarily for Parkinson’s but sometimes for depression, rasagiline-linked hair loss is extremely rare. Its MAO-B inhibition may theoretically influence follicle cycling. A single case in Clinical Neuropharmacology described temporary alopecia that resolved after stopping the drug.

Which Antidepressant Has the Highest Risk of Causing Hair Loss?

Among all antidepressants, bupropion (Wellbutrin) has the strongest documented association with hair loss. While most antidepressants cause rare and reversible shedding, multiple case reports and cohort studies suggest bupropion may trigger hair loss slightly more frequently than SSRIs, SNRIs, or atypical agents.

Which Antidepressant Has the Lowest Risk of Causing Hair Loss?

Many antidepressants are associated with extremely rare or negligible hair loss, particularly those with selective or targeted mechanisms that minimally disrupt hair follicle cycling. Among all classes, SSRIs such as fluvoxamine and MAOIs like selegiline have very few documented cases of hair loss, making them some of the safest options in this regard.

How Severe Is Hair Loss Caused by Antidepressants?

Hair loss caused by antidepressants is generally mild to moderate rather than severe. Most patients experience diffuse thinning of hair across the scalp.

The hair loss usually occurs 2 to 4 months after starting the antidepressant, and the condition can last 2 to 6 months if the medication is continued. Once the drug is reduced, switched, or discontinued, hair regrowth often begins within 2 to 3 months and is generally complete within 6 months.

A review in the International Journal of Trichology analyzed multiple case reports and small observational studies, concluding that antidepressant-induced hair loss is reversible and self-limiting, with severity ranging from mild thinning to moderate diffuse hair shedding, depending on the specific drug and patient susceptibility.

What Signs Indicate that Hair Loss May be From Antidepressants?

Certain antidepressants may trigger hair loss in susceptible individuals, usually presenting as telogen effluvium, a temporary shedding of hair.

Diffuse Thinning: Hair becomes noticeably thinner across the entire scalp rather than in isolated patches. This is the most common presentation of antidepressant-induced hair loss.
Increased Hair Shedding: Patients may notice more hair falling out during brushing, washing, or on pillows and clothing.
Temporal Onset: Hair loss often begins 2 to 4 months after starting the medication, which aligns with the hair growth cycle.
Reversible Pattern: Shedding is generally temporary, and hair often starts to regrow 2–3 months after discontinuation or dose adjustment.
No Scalp Inflammation or Pain: Unlike alopecia areata or other dermatologic conditions, antidepressant-induced hair loss is typically not associated with redness, itching, or scalp irritation.
Symmetry: Hair loss usually occurs evenly on both sides of the scalp rather than in patchy areas, which helps distinguish it from other hair disorders.

What to Do If You Notice Hair Loss on Antidepressants

If you experience hair loss while taking antidepressants, the following steps can help manage the situation and determine whether the medication is the cause:

Consult Your Healthcare Provider: Discuss the hair loss with your prescribing doctor or psychiatrist. They can evaluate whether the antidepressant is causing the problem and weigh the risks and benefits of continuing treatment.
Review Medication History: Note when the hair loss began in relation to starting or changing your antidepressant. Timing can help determine whether the drug is likely responsible.
Consider Dose Adjustment: Under medical supervision, your doctor may reduce the dose to see if hair loss improves while still maintaining therapeutic benefits.
Switch Medications if Necessary: If hair loss persists, your doctor may suggest an alternative antidepressant with a lower reported risk of hair shedding.
Supportive Hair Care: Use gentle shampoos, avoid excessive heat styling, and minimize harsh chemical treatments to reduce additional stress on hair follicles.
Monitor Progress: Track hair shedding over time. Most antidepressant-related hair loss is temporary and regrowth typically begins 2–3 months after discontinuation or adjustment.
Consider Supplements or Nutrition Support: Ensure adequate intake of protein, iron, zinc, and biotin, which support healthy hair growth. Only take supplements after consulting your healthcare provider.

Can Adjusting the Dosage Reduce the Risk of Hair Thinning?

Yes, adjusting the dosage of an antidepressant can sometimes reduce the risk of hair thinning, particularly if the hair loss is dose-dependent or linked to individual sensitivity at higher levels of the drug. Lowering the dosage under medical supervision can help mitigate this side effect while maintaining therapeutic benefits.

Why Is It Dangerous to Stop Antidepressants Without Medical Supervision?

Stopping antidepressants without medical supervision is very dangerous because abrupt discontinuation can trigger withdrawal symptoms, relapse of depression, or other psychiatric and physical complications. Antidepressants alter neurotransmitter levels in the brain, and sudden cessation can destabilize these systems, leading to both short-term and long-term risks.

Severe withdrawal symptoms (dizziness, nausea, flu-like symptoms, irritability, insomnia)
Relapse or worsening of depression or anxiety
Increased risk of suicidal thoughts or behaviors, especially in vulnerable patients
Mood swings, agitation, or confusion
Rare neurological effects, including sensory disturbances (“brain zaps”)

A doctor can create a safe tapering schedule, monitor for adverse effects, and ensure that mental health remains stable throughout the process. Stopping without guidance can lead to serious physical and psychological consequences.